Drug General Information
Drug ID	D08NXX
Former ID	DNC004193
Drug Name	BMY-20844
Drug Type	Small molecular drug
Indication	Discovery agent		Terminated	[544630]
Structure		Download 2D MOL 3D MOL
Formula	C12H11N3O
Canonical SMILES	CC1=C(C2=CC3=C(NC(=O)N3)N=C2C=C1)C
InChI	1S/C12H11N3O/c1-6-3-4-9-8(7(6)2)5-10-11(13-9)15-12(16)14-10/h3-5H,1-2H3,(H2,13,14,15,16)
InChIKey	ODCKPUDNMNCWMR-UHFFFAOYSA-N
PubChem Compound ID	5487281
Target and Pathway
Target(s)	CGMP-inhibited 3',5'-cyclic phosphodiesterase A	Target Info	Inhibitor	[526741]
KEGG Pathway	Purine metabolism
	cGMP-PKG signaling pathway
	cAMP signaling pathway
	Morphine addiction
Reactome	cGMP effects
	G alpha (s) signalling events
WikiPathways	miR-targeted genes in muscle cell - TarBase
	miR-targeted genes in lymphocytes - TarBase
References
Ref 544630	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000364)
Ref 526741	J Med Chem. 1992 Jul 10;35(14):2688-96.Inhibitors of blood platelet cAMP phosphodiesterase. 3. 1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-one derivatives with enhanced aqueous solubility.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.